Sensars Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $330K

  • Investors
  • 12

Sensars General Information

Description

Developer of an implantable neurostimulating device designed to restore foot sensation in patients with diabetic neuropathy. The company develops neurostimulation technology that targets sensory restoration, enabling patients with diabetes to prevent foot ulcers and improve mobility.

Contact Information

Website
www.sensars.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • P.O. Box Number 115
  • West Grove, PA
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • P.O. Box Number 115
  • West Grove, PA
  • United States

Sensars Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sensars Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Seed Round 01-Sep-2025 $330K Completed Product Development
14. Grant 01-May-2024 Completed Product Development
13. Seed Round 01-Feb-2024 Completed Pre-Clinical Trials
12. Grant 03-Jan-2024 Completed Product Development
11. Accelerator/Incubator 01-Jan-2024 Completed Product Development
10. Accelerator/Incubator 01-Dec-2023 Completed Product Development
9. Accelerator/Incubator Completed Pre-Clinical Trials
8. Grant 01-Apr-2021 Completed Pre-Clinical Trials
7. Grant 01-Nov-2019 $1.77M $128K Completed Pre-Clinical Trials
6. Grant 01-Jan-2019 $444K $128K Completed Pre-Clinical Trials
To view Sensars’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Sensars Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an implantable neurostimulating device designed to restore foot sensation in patients with diabetic neuropa
Therapeutic Devices
West Grove, PA
3 As of 2025

Zurich, Switzerland
 

Calgary, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sensars Competitors (3)

One of Sensars’s 3 competitors is MYNERVA, a Venture Capital-Backed company based in Zurich, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MYNERVA Venture Capital-Backed Zurich, Switzerland
Orpyx Venture Capital-Backed Calgary, Canada
RxFunction Venture Capital-Backed Eden Prairie, MN
You’re viewing 3 of 3 competitors. Get the full list »

Sensars Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Sensars Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025191558-A1 A delivery tool assembly and a method of use Pending 10-Mar-2024
WO-2025191560-A1 A wallet assembly to be placed around a nerve and a method thereof Pending 10-Mar-2024
WO-2025191559-A1 An apparatus for anchoring and strain relief of electrode microwires within a nerve Pending 10-Mar-2024 A61N1/0558

Sensars Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sensars Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Healthcare Shares Venture Capital Minority
Bundesministerium für Bildung und Forschung Government
Health Wildcatters Accelerator/Incubator Minority
Gold Track Accelerator/Incubator
DIH-HERO Corporation
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Sensars FAQs

  • When was Sensars founded?

    Sensars was founded in 2014.

  • Where is Sensars headquartered?

    Sensars is headquartered in West Grove, PA.

  • What is the size of Sensars?

    Sensars has 3 total employees.

  • What industry is Sensars in?

    Sensars’s primary industry is Therapeutic Devices.

  • Is Sensars a private or public company?

    Sensars is a Private company.

  • What is Sensars’s current revenue?

    The current revenue for Sensars is .

  • How much funding has Sensars raised over time?

    Sensars has raised $1.19M.

  • Who are Sensars’s investors?

    Healthcare Shares, Bundesministerium für Bildung und Forschung, Health Wildcatters, Gold Track, and DIH-HERO are 5 of 12 investors who have invested in Sensars.

  • Who are Sensars’s competitors?

    MYNERVA, Orpyx, and RxFunction are competitors of Sensars.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process